Industry Experts

Bernardo Sgarbi Reis is Director and Head of Immunology at Sanavia Oncology, where he leads discovery and preclinical development of therapeutic antibodies and multispecific formats targeting tumor-associated antigens. His group's work spans antibody engineering, immune cell engagement strategies, and translational immuno-oncology, with collaborative programs in CAR-T and antibody-drug conjugates. He brings a systems-level perspective on building-block selection and compatibility — bridging biophysical, functional, and manufacturability considerations that determine whether a multispecific format succeeds beyond the bench.